Antimicrobials
Foscarnet

Foscarnet

Restricted

N/A
N/A

General Information

  • May cause renal impairment, electrolyte disturbances, anemia, headache, and GI disturbances

Injection: 6000 mg/250 mL vial

  • Ganciclovir/valganciclovir is first-line for CMV infection
  • Consultation with Infectious Diseases is strongly encouraged
  • Duration of treatment depends on indication and response; ideally continue until serum/plasma viral load is undetectable. Weak evidence for secondary prophylaxis.
  • Hydration recommended prior to each dose: 10-20 mL/kg normal saline or other appropriate fluid prior to each dose (usual adult hydration 750 - 1000 mL prior to first dose and 500 - 750 mL prior to subsequent doses)